Cargando…
Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study
The utility of pharmacist consultation for drug-induced liver injury (DILI) management has not been explored. This retrospective cohort study evaluated the impact of a pharmacist active consultation (PAC) service on the management and outcome in patients with DILI. Consecutive patients meeting clini...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468675/ https://www.ncbi.nlm.nih.gov/pubmed/36110542 http://dx.doi.org/10.3389/fphar.2022.972800 |
_version_ | 1784788466716901376 |
---|---|
author | Li, Dongxuan Dong, Jie Xi, Xin Huang, Guili Li, Wenjun Chen, Cheng Liu, Jun Du, Qian Liu, Songqing |
author_facet | Li, Dongxuan Dong, Jie Xi, Xin Huang, Guili Li, Wenjun Chen, Cheng Liu, Jun Du, Qian Liu, Songqing |
author_sort | Li, Dongxuan |
collection | PubMed |
description | The utility of pharmacist consultation for drug-induced liver injury (DILI) management has not been explored. This retrospective cohort study evaluated the impact of a pharmacist active consultation (PAC) service on the management and outcome in patients with DILI. Consecutive patients meeting clinical biochemical criteria for DILI were enrolled at a tertiary teaching hospital between 1 January 2020 and 30 April 2022. The Roussel Uclaf Causality Assessment Method was used to assess causality between drug use and liver injury for each suspected DILI patient. Included patients were grouped according to whether they received PAC, and a proportional hazard model with multivariate risk adjustment, inverse probability of treatment weighting (IPTW), and propensity score matching (PSM) was used to assess DILI recovery. In the PSM cohort, the quality of medical care was compared between PAC and no PAC groups. A total of 224 patients with DILI (108 who received PAC and 116 who did not) were included in the analysis. Of these patients, 11 (10%) were classified as highly probable, 58 (54%) as probable, and 39 (36%) as possible DILI in the PAC group, while six patients (5%) were classified as highly probable, 53 (46%) as probable, and 57 (49%) as possible DILI in the no PAC group (p = 0.089). During patient recovery, PAC was associated with a ∼10% increase in the cumulative 180-day recovery rate. The PAC group had a crude hazard ratio (HR) of 1.73 [95% confidence interval (CI): 1.23–2.43, p = 0.001] for DILI 180-day recovery, which remained stable after multivariate risk adjustment (HR = 1.74, 95% CI: 1.21–2.49, p = 0.003), IPTW (HR = 1.72, 95% CI: 1.19–2.47, p = 0.003), and PSM (HR = 1.49, 95% CI: 1.01–2.23, p = 0.046). In the PSM cohort, PAC was more likely to identify suspect drugs (90% vs. 60%, p < 0.001) and lead to timely withdrawal of the medication (89% vs. 57%, p < 0.001). Thus, PAC is associated with a better quality of medical care for patients with DILI and can improve patient outcomes. |
format | Online Article Text |
id | pubmed-9468675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94686752022-09-14 Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study Li, Dongxuan Dong, Jie Xi, Xin Huang, Guili Li, Wenjun Chen, Cheng Liu, Jun Du, Qian Liu, Songqing Front Pharmacol Pharmacology The utility of pharmacist consultation for drug-induced liver injury (DILI) management has not been explored. This retrospective cohort study evaluated the impact of a pharmacist active consultation (PAC) service on the management and outcome in patients with DILI. Consecutive patients meeting clinical biochemical criteria for DILI were enrolled at a tertiary teaching hospital between 1 January 2020 and 30 April 2022. The Roussel Uclaf Causality Assessment Method was used to assess causality between drug use and liver injury for each suspected DILI patient. Included patients were grouped according to whether they received PAC, and a proportional hazard model with multivariate risk adjustment, inverse probability of treatment weighting (IPTW), and propensity score matching (PSM) was used to assess DILI recovery. In the PSM cohort, the quality of medical care was compared between PAC and no PAC groups. A total of 224 patients with DILI (108 who received PAC and 116 who did not) were included in the analysis. Of these patients, 11 (10%) were classified as highly probable, 58 (54%) as probable, and 39 (36%) as possible DILI in the PAC group, while six patients (5%) were classified as highly probable, 53 (46%) as probable, and 57 (49%) as possible DILI in the no PAC group (p = 0.089). During patient recovery, PAC was associated with a ∼10% increase in the cumulative 180-day recovery rate. The PAC group had a crude hazard ratio (HR) of 1.73 [95% confidence interval (CI): 1.23–2.43, p = 0.001] for DILI 180-day recovery, which remained stable after multivariate risk adjustment (HR = 1.74, 95% CI: 1.21–2.49, p = 0.003), IPTW (HR = 1.72, 95% CI: 1.19–2.47, p = 0.003), and PSM (HR = 1.49, 95% CI: 1.01–2.23, p = 0.046). In the PSM cohort, PAC was more likely to identify suspect drugs (90% vs. 60%, p < 0.001) and lead to timely withdrawal of the medication (89% vs. 57%, p < 0.001). Thus, PAC is associated with a better quality of medical care for patients with DILI and can improve patient outcomes. Frontiers Media S.A. 2022-08-30 /pmc/articles/PMC9468675/ /pubmed/36110542 http://dx.doi.org/10.3389/fphar.2022.972800 Text en Copyright © 2022 Li, Dong, Xi, Huang, Li, Chen, Liu, Du and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Dongxuan Dong, Jie Xi, Xin Huang, Guili Li, Wenjun Chen, Cheng Liu, Jun Du, Qian Liu, Songqing Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study |
title | Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study |
title_full | Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study |
title_fullStr | Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study |
title_full_unstemmed | Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study |
title_short | Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: A retrospective cohort study |
title_sort | impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general hospital wards: a retrospective cohort study |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468675/ https://www.ncbi.nlm.nih.gov/pubmed/36110542 http://dx.doi.org/10.3389/fphar.2022.972800 |
work_keys_str_mv | AT lidongxuan impactofpharmacistactiveconsultationonclinicaloutcomesandqualityofmedicalcareindruginducedliverinjuryinpatientsingeneralhospitalwardsaretrospectivecohortstudy AT dongjie impactofpharmacistactiveconsultationonclinicaloutcomesandqualityofmedicalcareindruginducedliverinjuryinpatientsingeneralhospitalwardsaretrospectivecohortstudy AT xixin impactofpharmacistactiveconsultationonclinicaloutcomesandqualityofmedicalcareindruginducedliverinjuryinpatientsingeneralhospitalwardsaretrospectivecohortstudy AT huangguili impactofpharmacistactiveconsultationonclinicaloutcomesandqualityofmedicalcareindruginducedliverinjuryinpatientsingeneralhospitalwardsaretrospectivecohortstudy AT liwenjun impactofpharmacistactiveconsultationonclinicaloutcomesandqualityofmedicalcareindruginducedliverinjuryinpatientsingeneralhospitalwardsaretrospectivecohortstudy AT chencheng impactofpharmacistactiveconsultationonclinicaloutcomesandqualityofmedicalcareindruginducedliverinjuryinpatientsingeneralhospitalwardsaretrospectivecohortstudy AT liujun impactofpharmacistactiveconsultationonclinicaloutcomesandqualityofmedicalcareindruginducedliverinjuryinpatientsingeneralhospitalwardsaretrospectivecohortstudy AT duqian impactofpharmacistactiveconsultationonclinicaloutcomesandqualityofmedicalcareindruginducedliverinjuryinpatientsingeneralhospitalwardsaretrospectivecohortstudy AT liusongqing impactofpharmacistactiveconsultationonclinicaloutcomesandqualityofmedicalcareindruginducedliverinjuryinpatientsingeneralhospitalwardsaretrospectivecohortstudy |